Clinical Trial Search Results for "TIMI 2B"

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. The TIMI Study Group. N Engl J Med. 1989;320:618-27. Abstract

Gibbons, R. J., Verani, M. S., Behrenbeck, T., Pellikka, P. A., O'Connor, M. K., Mahmarian, J. J., Chesebro, J. H., Wackers, F. J. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction Circulation. 1989;80(5):1277-86. Abstract

Gore, J. M., Corrao, J. M., Goldberg, R. J., Ball, S. P., Weiner, B. H., Aghababian, R. V., Dalen, J. E. Feasibility and safety of emergency interhospital transport of patients during early hours of acute myocardial infarction Archives of internal medicine. 1989;149(2):353-5. Abstract

Sharkey, S. W., Bruneete, D. D., Ruiz, E., Hession, W. T., Wysham, D. G., Goldenberg, I. F., Hodges, M. An analysis of time delays preceding thrombolysis for acute myocardial infarction JAMA. 1989;262(22):3171-4. Abstract

Wackers, F. J., Gibbons, R. J., Verani, M. S., Kayden, D. S., Pellikka, P. A., Behrenbeck, T., Mahmarian, J. J., Zaret, B. L. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy Journal of the American College of Cardiology. 1989;14(4):861-73. Abstract

Feit, F., Mueller, H. S., Braunwald, E., Ross, R., Hodges, M., Herman, M. V., Knatterud, G. L. Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group Journal of the American College of Cardiology. 1990;16(7):1529-34. Abstract

Hillis, L. D., Forman, S., Braunwald, E. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators Journal of the American College of Cardiology. 1990;16(2):313-5. Abstract

Johnson, L. L., Seldin, D. W., Keller, A. M., Wall, R. M., Bhatia, K., Bingham, C. O., 3rd, Tresgallo, M. E. Dual isotope thallium and indium antimyosin SPECT imaging to identify acute infarct patients at further ischemic risk Circulation. 1990;81(1):37-45. Abstract

Kayden, D. S., Wackers, F. J., Zaret, B. L. Silent left ventricular dysfunction during routine activity after thrombolytic therapy for acute myocardial infarction Journal of the American College of Cardiology. 1990;15(7):1500-7. Abstract

Lawler, C. M., Bovill, E. G., Stump, D. C., Collen, D. J., Mann, K. G., Tracy, R. P. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction Blood. 1990;76(7):1341-8. Abstract

Bovill, E. G., Terrin, M. L., Stump, D. C., Berke, A. D., Frederick, M., Collen, D., Feit, F., Gore, J. M., Hillis, L. D., Lambrew, C. T., et al., Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial Annals of internal medicine. 1991;115(4):256-65. Abstract

Gore, J. M., Sloan, M., Price, T. R., Randall, A. M., Bovill, E., Collen, D., Forman, S., Knatterud, G. L., Sopko, G., Terrin, M. L. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial Circulation. 1991;83(2):448-59. Abstract

Roberts R, Rogers WJ, Mueller HS, Lambrew CT, Diver DJ, Smith HC, Willerson JT, Knatterud GL, Forman S, Passamani E, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation. 1991;83:422-37. Abstract

Rogers, W. J., Babb, J. D., Baim, D. S., Chesebro, J. H., Gore, J. M., Roberts, R., Williams, D. O., Frederick, M., Passamani, E. R., Braunwald, E. Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators Journal of the American College of Cardiology. 1991;17(5):1007-16. Abstract

Baim, D. S., Diver, D. J., Feit, F., Greenberg, M. A., Holmes, D. R., Weiner, B. H., Williams, D. O., Schweiger, M. J., Brown, B. G., Frederick, M. M., et al., Coronary angioplasty performed within the Thrombolysis in Myocardial Infarction II study Circulation. 1992;85(1):93-105. Abstract

Berger, P. B., Ruocco, N. A., Jr., Ryan, T. J., Frederick, M. M., Jacobs, A. K., Faxon, D. P. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II Journal of the American College of Cardiology. 1992;20(3):533-40. Abstract

Kleiman, N. S., Terrin, M., Mueller, H., Chaitman, B., Roberts, R., Knatterud, G. L., Solomon, R., McMahon, R. P., Braunwald, E. Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study Journal of the American College of Cardiology. 1992;19(6):1129-35. Abstract

Mueller, H. S., Cohen, L. S., Braunwald, E., Forman, S., Feit, F., Ross, A., Schweiger, M., Cabin, H., Davison, R., Miller, D., et al., Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II Circulation. 1992;85(4):1254-64. Abstract

Ruocco, N. A., Jr., Bergelson, B. A., Jacobs, A. K., Frederick, M. M., Faxon, D. P., Ryan, T. J. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II) Journal of the American College of Cardiology. 1992;20(7):1445-51. Abstract

Tofler, G. H., Muller, J. E., Stone, P. H., Forman, S., Solomon, R. E., Knatterud, G. L., Braunwald, E. Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group Journal of the American College of Cardiology. 1992;20(5):1049-55. Abstract

Williams, D. O., Braunwald, E., Knatterud, G., Babb, J., Bresnahan, J., Greenberg, M. A., Raizner, A., Wasserman, A., Robertson, T., Ross, R. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial Circulation. 1992;85(2):533-42. Abstract

Zaret, B. L., Wackers, F. J., Terrin, M. L., Ross, R., Weiss, M., Slater, J., Morrison, J., Bourge, R. C., Passamani, E., Knatterud, G., et al., Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II Study American journal of cardiology. 1992;69(1):9-Jan. Abstract

Berger, P. B., Ruocco, N. A., Jr., Ryan, T. J., Jacobs, A. K., Zaret, B. L., Wackers, F. J., Frederick, M. M., Faxon, D. P. Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research Group American journal of cardiology. 1993;71(13):1148-52. Abstract

Berger, P. B., Ruocco, N. A., Ryan, T. J., Frederick, M. M., Podrid, P. J. Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial Journal of the American College of Cardiology. 1993;22(7):1773-9. Abstract

Chaitman, B. R., McMahon, R. P., Terrin, M., Younis, L. T., Shaw, L. J., Weiner, D. A., Frederick, M. M., Knatterud, G. L., Sopko, G., Braunwald, E. Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial American journal of cardiology. 1993;71(2):131-8. Abstract

Simoons, M. L., Maggioni, A. P., Knatterud, G., Leimberger, J. D., de Jaegere, P., van Domburg, R., Boersma, E., Franzosi, M. G., Califf, R., Schroder, R., et al., Individual risk assessment for intracranial haemorrhage during thrombolytic therapy Lancet. 1993;342(8886-8887):1523-8. Abstract

Taylor, H. A., Chaitman, B. R., Rogers, W. J., Kern, M. J., Terrin, M. L., Aguirre, F. V., Sopko, G., McMahon, R., Ross, R. N., Bovill, E. C. Race and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial Circulation. 1993;88(4 Pt 1):1484-94. Abstract

Terrin, M. L., Williams, D. O., Kleiman, N. S., Willerson, J., Mueller, H. S., Desvigne-Nickens, P., Forman, S. A., Knatterud, G. L., Braunwald, E. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial Journal of the American College of Cardiology. 1993;22(7):1763-72. Abstract

Aguirre, F. V., McMahon, R. P., Mueller, H., Kleiman, N. S., Kern, M. J., Desvigne-Nickens, P., Hamilton, W. P., Chaitman, B. R. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators Circulation. 1994;90(1):78-86. Abstract

Becker, R. C., Terrin, M., Ross, R., Knatterud, G. L., Desvigne-Nickens, P., Gore, J. M., Braunwald, E. Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators Annals of internal medicine. 1994;120(8):638-45. Abstract

Cox, D. A., Rogers, W. J., Aguirre, F. V., Forman, S., Solomon, R., Zaret, B. L. Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators American journal of cardiology. 1994;73(11):729-36. Abstract

Schweiger, M. J., McMahon, R. P., Terrin, M. L., Ruocco, N. A., Porway, M. N., Wiseman, A. H., Knatterud, G. L., Braunwald, E. Comparison of patients with < 60% to > or = 60% diameter narrowing of the myocardial infarct-related artery after thrombolysis. The TIMI Investigators American journal of cardiology. 1994;74(2):105-10. Abstract

Aguirre, F. V., Younis, L. T., Chaitman, B. R., Ross, A. M., McMahon, R. P., Kern, M. J., Berger, P. B., Sopko, G., Rogers, W. J., Shaw, L., et al., Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study Circulation. 1995;91(10):2541-8. Abstract

Gersh, B. J., Chesebro, J. H., Braunwald, E., Lambrew, C., Passamani, E., Solomon, R. E., Ross, A. M., Ross, R., Terrin, M. L., Knatterud, G. L. Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II) Journal of the American College of Cardiology. 1995;25(2):395-402. Abstract

Hall, C., Cannon, C. P., Forman, S., Braunwald, E. Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II Investigators Journal of the American College of Cardiology. 1995;26(6):1452-6. Abstract

Mueller, Hiltrud S., Forman, Sandra A., Menegus, Mark A., Cohen, Lawrence S., Knatterud, Genell L., Braunwald, Eugene Prognostic significance of nonfatal reinfarction during 3-year follow-up: Results of the thrombolysis in myocardial infarction (TIMI) phase II clinical trial Journal of the American College of Cardiology. 1995;26(4):900-907.

Sloan, M. A., Price, T. R., Petito, C. K., Randall, A. M., Solomon, R. E., Terrin, M. L., Gore, J., Collen, D., Kleiman, N., Feit, F., et al., Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience Neurology. 1995;45(4):649-58. Abstract

Zaret, B. L., Wackers, F. J., Terrin, M. L., Forman, S. A., Williams, D. O., Knatterud, G. L., Braunwald, E. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group Journal of the American College of Cardiology. 1995;26(1):73-9. Abstract

Callas, P. W., Tracy, R. P., Bovill, E. G., Cannon, C., Thompson, B., Mann, K. G. The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thromholysis in Myocardial Infarction Phase II (TIMI II) Trial Journal of thrombosis and thrombolysis. 1998;5(1):53-60. Abstract

Tracy, R. P., Kleiman, N. S., Thompson, B., Cannon, C. P., Bovill, E. G., Brown, R. G., Collen, D., Mahan, E., Mann, K. G., Rogers, W. J., Sopko, G., Stump, D. C., Williams, D. O., Zaret, B. L. Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial American heart journal. 1998;135(1):29-37. Abstract